Free Trial

DocuSign, Inc. (NASDAQ:DOCU) Shares Purchased by Pathstone Holdings LLC

DocuSign logo with Computer and Technology background

Pathstone Holdings LLC increased its stake in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 2.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 141,057 shares of the company's stock after purchasing an additional 3,714 shares during the quarter. Pathstone Holdings LLC owned 0.07% of DocuSign worth $12,687,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Kestra Investment Management LLC purchased a new position in DocuSign during the 4th quarter valued at $30,000. First Horizon Advisors Inc. lifted its holdings in shares of DocuSign by 102.6% in the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company's stock worth $36,000 after buying an additional 201 shares during the period. Bessemer Group Inc. lifted its holdings in shares of DocuSign by 490.0% in the 4th quarter. Bessemer Group Inc. now owns 472 shares of the company's stock worth $42,000 after buying an additional 392 shares during the period. Avion Wealth lifted its holdings in shares of DocuSign by 309.2% in the 4th quarter. Avion Wealth now owns 487 shares of the company's stock worth $43,000 after buying an additional 368 shares during the period. Finally, Avior Wealth Management LLC lifted its holdings in shares of DocuSign by 36.5% in the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company's stock worth $49,000 after buying an additional 145 shares during the period. Institutional investors own 77.64% of the company's stock.

DocuSign Trading Down 1.2%

NASDAQ:DOCU traded down $1.11 during trading hours on Monday, hitting $91.31. 1,507,051 shares of the stock were exchanged, compared to its average volume of 2,757,230. The company has a market cap of $18.49 billion, a P/E ratio of 18.83, a P/E/G ratio of 6.94 and a beta of 1.21. The firm's fifty day moving average price is $81.19 and its 200 day moving average price is $85.31. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86.

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.02. The business had revenue of $776.25 million for the quarter, compared to analysts' expectations of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business's revenue for the quarter was up 9.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.76 EPS. Equities analysts expect that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Blake Jeffrey Grayson sold 8,000 shares of the stock in a transaction on Tuesday, April 15th. The stock was sold at an average price of $76.09, for a total value of $608,720.00. Following the transaction, the chief financial officer now owns 86,156 shares of the company's stock, valued at $6,555,610.04. This represents a 8.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Teresa Briggs sold 534 shares of the firm's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $87.41, for a total value of $46,676.94. Following the transaction, the director now directly owns 8,270 shares in the company, valued at approximately $722,880.70. The trade was a 6.07% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 47,851 shares of company stock worth $3,912,239 over the last ninety days. Corporate insiders own 1.01% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on DOCU. UBS Group decreased their price objective on DocuSign from $90.00 to $85.00 and set a "neutral" rating for the company in a research note on Thursday, April 17th. Hsbc Global Res raised DocuSign from a "moderate sell" rating to a "hold" rating in a research report on Friday, April 11th. Citigroup raised their price objective on DocuSign from $113.00 to $115.00 and gave the stock a "buy" rating in a research report on Friday, March 14th. Robert W. Baird set a $93.00 price target on DocuSign in a research report on Friday, March 14th. Finally, Bank of America lowered their price target on DocuSign from $112.00 to $98.00 and set a "neutral" rating for the company in a research report on Friday, March 14th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $92.46.

View Our Latest Analysis on DocuSign

DocuSign Company Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Articles

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Should You Invest $1,000 in DocuSign Right Now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines